Overview
Jack Hong is a Hematologist Oncology specialist and a Radiation Oncologist in Baltimore, Maryland. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Laryngeal Cancer, Breast Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast.
His clinical research consists of participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 3 clinical trials in the study of Small Cell Lung Cancer (SCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
22 S Green St, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
16 Clinical Trials
University Of Maryland Oncology Associates PA
Taofeek Owonikoko is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Owonikoko is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Russell Hales, M.D., is an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also is director of the thoracic multidisciplinary clinic. His research focuses on reconstructing health delivery models to enhance value and improve clinical outcomes. He also studies the effect of immunotherapy and RT in thoracic tumors. Dr. Hales was awarded an R21 grant to study the use of dynamic MRI in predicting tumor motion in patient with lung cancer. Taken together, his research focuses on optimizing patient outcomes using resources from physics, engineering, biology and health delivery systems. Dr. Hales’ efforts extend beyond radiation oncology and clinical management. He has helped to lead in the thoracic oncology program, which includes 20 faculty members and nearly 50 staff, to help chart a vision for this program’s future. In the last four years, the program has gradually transitioned from The Johns Hopkins Hospital campus to Johns Hopkins Bayview Medical Center. Dr. Hales was tasked to head the building and design committee that worked with architects to create a structure conducive to 21st century oncology care. His work extends beyond the bricks and mortar of the new cancer center today to team development within the thoracic oncology program. Simply put, the thoracic oncology move was designed to conceptualize the transition of care from department-based to disease-based medicine. As such, Dr. Hales has worked to integrate the efforts of specialists in medical oncology, thoracic surgery, interventional pulmonology, pathology and radiology. These experts share a clinical space focused on thoracic malignancies and bring a patient-centered model of care to their group. Dr. Hales graduated from Brigham Young University Summa Cum Laude and Valedictorian in 2001. He attended Johns Hopkins Medicine and graduated with an M.D. in 2005. He trained on the Osler Medical Service and attended residency at Johns Hopkins. He joined the faculty at Hopkins in 2010. Dr. Hales focus in program building, research and clinical endeavors is robust, but he understands the key role of academia in training future leaders in medicine. He has been awarded Teacher of the Year in the department of radiation oncology at Hopkins for three of the last six years. He is a well-respected lecturer and travels nationally to speak at conferences and educational workshops about novel therapies in lung and esophagus cancer. Make A Gift. Dr. Hales is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Thymic Epithelial Tumor, Non-Small Cell Lung Cancer (NSCLC), and Endoscopy.
Patrick Forde is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Forde is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, Small Cell Lung Cancer (SCLC), and Bone Marrow Transplant. Dr. Forde is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Hong isDistinguished. Learn about Breast Cancer.
- Familial Prostate CancerDr. Hong isDistinguished. Learn about Familial Prostate Cancer.
- Laryngeal CancerDr. Hong isDistinguished. Learn about Laryngeal Cancer.
- Paget Disease of the BreastDr. Hong isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Hong isDistinguished. Learn about Pleuropulmonary Blastoma.
- Prostate CancerDr. Hong isDistinguished. Learn about Prostate Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Hong isAdvanced. Learn about Anal Cancer.
- Lung AdenocarcinomaDr. Hong isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hong isAdvanced. Learn about Lung Cancer.
- Squamous Cell Lung CarcinomaDr. Hong isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Throat CancerDr. Hong isAdvanced. Learn about Throat Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Hong isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Hong isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Hong isExperienced. Learn about Angiosarcoma.
- Bladder CancerDr. Hong isExperienced. Learn about Bladder Cancer.
- Bone TumorDr. Hong isExperienced. Learn about Bone Tumor.
- Breast Cancer in MenDr. Hong isExperienced. Learn about Breast Cancer in Men.
